CTS funds China

投资医疗一级市场
Website:
N/A
Partnering Objectives
Headquartner in China
圣忆 姜
董事总经理 

CubeTech Holdings United States

Late stage venture family office
Website:
www.asset3.com
Company Size (Fulltime employees)
Please specify your partnering goal
Investments
Headquartner in China
Mr. Shan Chen
President 
Functionality

CUBIO Innovation Center United States

Mark Wesson
Mentor, Chief Financial Officer 
Wesley Okeke
CEO 
Margaret Wong
Mentor, Regulatory/Compliance Advisor 

Curegenix China

A clinical stage company
Partnering Objectives
Headquartner in China
Michael An
Ceo 

CureMeta United States

CureMeta is a therapeutic oncology biotech with the mission to develop therapeutic antibodies to novel cancer targets that are present in aggressive cancers and to develop new powerful cancer drugs to provide meaningful treatments and cures for patients with metastatic cancer.

We are seeking partners to out-license our lead therapeutic: CM-09, a first in class Antibody-Drug-Conjuate for gastric cancers.

Website:
CureMeta.com
Company Size (Fulltime employees)
Year of foundation
2012
Partnering Objectives
Headquartner in China
Biotech/Pharma Category
Assets Information 1
CM-09, a first-in-class Antibody-Drug-Conjugate for gastric and pancreatic cancers. US patent awarded, patent filed in China, Japan, South Korea, Russian, Australia, India, Brazil and Europe.
Slides Deck
(pdf, 2.95MB)
Dr. MIke Schopperle
CSO 

Curika India

CURIKA, our health based app aims to revolutionize healthcare delivery through mobile/web based platform. We connect Patients, Doctors, Nurses, and Diagnostic Centres across geographies, technology and workflow boundaries. We provide online medical equipment (Rent / Purchase), Nursing Staff, Physiotherapist & Ayurvedic Therapist at door step of end user.
Company Size (Fulltime employees)
Please specify your partnering goal
Investment
Headquartner in China
Medtech Category
Mr. Anil Nair
CEO 
Functionality

Curon China

Curon biopharma is a clinical stage biopharmaceutical company focused on next generation anti-cancer therapies
Website:
N/A
Partnering Objectives
Headquartner in China
Natasha Qin
BD Director 

Cushman China

戴德梁行 国际五大行之一
Website:
Cushman.com
Partnering Objectives
Headquartner in China
Bella Zhou
Associate director 

Cytiva China

Cytiva is a global provider of technologies and services that help advance and accelerate the development and manufacture of therapeutics. Previously GE Healthcare Life Sciences, Cytiva’s diverse portfolio includes well-recognized brands such as ÄKTA, Amersham, Biacore, FlexFactory, HyClone, MabSelect, Sefia, Whatman, Xcellerex and Xuri. Cytiva brings speed, efficiency and capacity to research and manufacturing workflows, enabling the delivery of transformative medicines to patients. Visit cytiva.com for more information
Website:
cytiva.com
Company Size (Fulltime employees)
Please specify your partnering goal
Seeking genomics, bioprocess and cell & gene therapy technologies for licensing and other partnership opportunities
Headquartner in China
Dr. Daniel Floyd
Search and Evaluation Director, Asia 
Functionality

CytomX Therapeutics

Clinical stage bio pharmaceutical company with Probody platform to treat cancer.
Website:
cytomx.com
Partnering Objectives
Headquartner in China
Biotech/Pharma Category
Simon He
Director of Finance